Jia Liu, Conjoint Associate Professor at UNSW, ESMO Leadership Development Programme (LDP) Participant, shared Journal of Clinical Oncology’s post on X, adding:
“Precision drug development cannot stop at identifying the right target or therapy.
We also need to solve the “last mile”: getting the right patient to the right trial at the right time.
Important call for pragmatism and patient centricity in modern drug development from Dr. Elizabeth Jaffee, Journal of Clinical Oncology, UT MD Anderson.”
Quoting Journal of Clinical Oncology’s post:
“Modernizing Drug Development for Exceptional Therapies in High‑Unmet Need Diseases: A Call for Pragmatism and Patient Centricity.”
Title: Modernizing Drug Development for Exceptional Therapies in High‑Unmet Need Diseases: A Call for Pragmatism and Patient Centricity
Authors: Elizabeth M. Jaffee, Timothy A. Yap.
Other articles about Jia Liu on OncoDaily.